HVEGF-IN-1
HVEGF-IN-1, a quinazoline derivative, could specifically bind to the G-rich sequence in the internal ribosome entry site A (IRES-A) and destabilize the G-quadruplex structure. hVEGF-IN-1 binds to the IRES-A (WT) with a Kd of 0.928 μM in SPR experiments. hVEGF-IN-1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF-A protein expression[1].
Product Specifications
CAS Number
1637443-98-1
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hVEGF-IN-1.html
Purity
99.26
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CCN(CC)CCOC(C=C1)=CC=C1NC2=NC(C3=C(NC(CCN4CCN(C)CC4)=O)C=CC=C3)=NC5=CC=CC=C52
Molecular Formula
C34H43N7O2
Molecular Weight
581.75
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GalNacb(1,4)Galb-O-BSA Colloidal Gold Conjugate, 1mL 5nm
![PSMB8 Rabbit Monoclonal Antibody [Clone ID: R09-1H1]](https://cdn.genprice.uk/products/937/68dd1b5b061270361ea0ff43/imageurl/ta385069.webp)